Pharmaceutical Manufacturing of Dutasteride 0.5mg Capsules

The contract involves the subcontract manufacturing of Dutasteride 0.5mg capsules in bulk form that meet FDA compliance standards. This manufacturing process occurs prior to the final packaging stage. The contract is issued by Nac Pharmaceuticals, operating under the Department of Veterans Affairs, and falls under the NAICS code 325412, which pertains to pharmaceutical preparations manufacturing. The solicitation was posted on June 16, 2026, with responses due by July 7, 2026. Key elements of the contract include the focus on producing Dutasteride capsules strictly according to FDA guidelines to ensure quality and regulatory adherence. While specific location details for performance and agency office address are not provided, the contract clearly targets subcontractors capable of handling pharmaceutical manufacturing activities. This opportunity is public and accessible via the provided SAM.gov link for interested parties to review and respond before the stated deadline.